跳至主要内容
临床试验/NCT02153294
NCT02153294已完成不适用

PRotective VENTilation in Patients Without ARDS at Start of Ventilation - PReVENT, a Randomized Controlled Trial

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 个研究点 分布在 1 个国家目标入组 952 人开始时间: 2014年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
952
试验地点
1
主要终点
Ventilator-free days

研究概览

简要总结

The purpose of this national multicentre randomized controlled trial is to compare a ventilation strategy using lower tidal volumes and higher respiratory rates with a ventilation strategy using higher tidal volumes and a lower respiratory rate in intubated and ventilated intensive care unit (ICU) patients without Acute Respiratory Distress Syndrome (ARDS) at start of ventilation.

Participating centres in The Netherlands will include a total of 952 adult patients admitted to intensive care units without ARDS. Patients are randomized and ventilated with either a strategy with lower tidal volumes (4 to 6 ml/kg predicted body weight (PBW)) or a strategy with higher tidal volumes (8 to 10 ml/kg PBW). Patients will be assessed every day until day 28 or discharge of the intensive care unit, whichever comes first, on day 28 and on day 90. Primary endpoint is the number of ventilator-free days at day 28. Secondary endpoints are ICU- and hospital length of stay (LOS) and - mortality, the incidence of development of ARDS, pneumonia, atelectasis, and pneumothorax, the cumulative use and duration of sedatives, and neuromuscular blocking agents, incidences of ICU delirium and ICU acquired weakness, patient-ventilator asynchrony and the need for decreasing of instrumental dead space.

详细描述

Research question:

Does mechanical ventilation with lower tidal volumes, as compared with mechanical ventilation with higher tidal volumes, increase the number of ventilator-free days at day 28 in patients without ARDS at start of ventilation?

Study Design:

An investigator-initiated, national, multicenter, parallel randomized controlled two-arm trial.

Centers:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admission to an ICU participating in this trial
  • Need for intubation
  • Within 1 hour of admission from the operation room or emergency room (if still intubated and ventilated), or within 1 hour of start of invasive ventilation in the ICU
  • An expected duration of ventilation > 24 hours

排除标准

  • Age less than 18 years
  • Patients previously randomized in PReVENT
  • Patients participating in other interventional trials
  • Patients with a clinical diagnosis of ARDS according to the Berlin definition
  • Patients with a PaO2/FiO2 < 200 mm Hg in whom hypoxia is presumably not caused by cardiac failure or fluid overload
  • Invasive ventilation longer than 12 hours directly preceding admission
  • Patients with suspected or confirmed pregnancy
  • Patients with increased and uncontrollable intracranial pressure (of ≥18 mmHg)
  • Patients with GOLD classification III or IV chronic obstructive pulmonary disease (COPD)
  • Patients with asthmatic status
  • Patients with premorbid restrictive pulmonary disease (evidence of chronic interstitial infiltration on previous chest radiographs)
  • Patients with new proven pulmonary thrombo-embolism
  • Patients with any previous pneumectomy or lobectomy

研究组 & 干预措施

Ventilation with lower tidal volumes

Experimental

Use of low tidal volume (4 to 6 ml/kg PBW) after intubation and during all mechanical ventilation

干预措施: low tidal volume (Procedure)

Ventilation with higher tidal volumes

Other

Use of high tidal volume (8 to 10 ml/kg PBW) after intubation and during all mechanical ventilation

干预措施: high tidal volume (Procedure)

结局指标

主要结局

Ventilator-free days

时间窗: first 28 days after start of ventilation

The number of ventilator-free days, defined as the number of days from day 1 to day 28 on which a patient breathes without assistance, if the period of unassisted breathing lasted at least 24 consecutive hours.

次要结局

  • Intensive care unit length of stay(first 90 days after start of ventilation)
  • Cumulative use and duration of sedatives and neuromuscular blocking agents(first 28 days after start of ventilation or discharge from intensive care)
  • ICU delirium(first 28 days after start of ventilation or discharge from intensive care)
  • Pulmonary complications(first 28 days after start of ventilation or discharge from intensive care)
  • Hospital length of stay(first 90 days after start of ventilation)
  • ICU- Acquired Weakness(first 28 days after start of ventilation or discharge from intensive care)
  • Mortality(first 90 days after start of ventilation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. Marcus J. Schultz

Principal Investigator and Clinical Professor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

研究点 (1)

Loading locations...

相似试验